Works matching IS 02683369 AND DT 1999 AND VI 23 AND IP 11

Results: 19

Using at least 5×106/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1177, doi. 10.1038/sj.bmt.1701748

By:

Scheid, C;
Draube, A;
Reiser, M;
Schulz, A;
Chemnitz, J;
Nelles, S;
Fuchs, M;
Winter, S;
Wickramanayake, P D;
Diehl, V;
Söhngen, D

Publication type:

Article

Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1153, doi. 10.1038/sj.bmt.1701768

By:

Ibisch, C;
Gallot, G;
Vivien, R;
Diez, E;
Jotereau, F;
Garand, R;
Vié, H

Publication type:

Article

Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host–donor combination.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1145

By:

Grčević, D;
Batinić, D;
Ascensao, J L;
Marušić, M

Publication type:

Article

Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1201, doi. 10.1038/sj.bmt.1701771

By:

Au, W Y;
Lie, A K W;
Lee, C K;
Liang, R;
Kwong, Y L

Publication type:

Article

Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD).

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1197, doi. 10.1038/sj.bmt.1701772

By:

Gmeinhart, B;
Hinterberger, W;
Greinix, H T;
Rabitsch, W;
Kirnbauer, R;
Reiter, E;
Volc-Platzer, B

Publication type:

Article

Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1101, doi. 10.1038/sj.bmt.1701774

By:

Benet, I;
Prosper, F;
Marugan, I;
Lluch, A;
Arbona, C;
Castillo, I;
Solano, C;
Garcia-Conde, J

Publication type:

Article

Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1109, doi. 10.1038/sj.bmt.1701776

By:

Fietz, T;
Berdel, W E;
Rieder, H;
Reufi, B;
Hopp, H;
Thiel, E;
Knauf, W U

Publication type:

Article

A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1183, doi. 10.1038/sj.bmt.1701770

By:

Harper, J M;
Slayback, D L;
Dobkins, J A;
Allen, R D

Publication type:

Article

Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1117, doi. 10.1038/sj.bmt.1701778

By:

Okunieff, P;
Barrett, A J;
Phang, S E;
Li, A;
Constine, L S;
Williams, J P;
Rubin, P;
Wang, X;
Wu, T;
Chen, Y;
Ding, I

Publication type:

Article

High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1123, doi. 10.1038/sj.bmt.1701780

By:

Baker, K S;
Roncarolo, M-G;
Peters, C;
Bigler, M;
DeFor, T;
Blazar, B R

Publication type:

Article

Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1161, doi. 10.1038/sj.bmt.1701781

By:

Sobecks, R M;
Le Beau, M M;
Anastasi, J;
Williams, S F

Publication type:

Article

Opportunistic CNS infection after bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1167, doi. 10.1038/sj.bmt.1701782

By:

Maschke, M;
Dietrich, U;
Prumbaum, M;
Kastrup, O;
Turowski, B;
Schaefer, U W;
Diener, H C

Publication type:

Article

Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1139, doi. 10.1038/sj.bmt.1701784

By:

Weiss, L;
Slavin, S

Publication type:

Article

Case Report: Plasmodium vivax causing pancytopenia after allogeneic blood stem cell transplantation in CML.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1213, doi. 10.1038/sj.bmt.1701808

By:

Raina, V;
Sharma, A;
Gujral, S;
Kumar, R

Publication type:

Article

Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1095, doi. 10.1038/sj.bmt.1701786

By:

Jillella, A P;
Doria, R;
Khan, K;
Zelterman, D;
Ahmad, Y H;
Smith, B R;
Holmes, W;
Becker, P;
Roberts, K B;
Rappeport, J M

Publication type:

Article

Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1209, doi. 10.1038/sj.bmt.1701788

By:

Chakrabarti, S;
Collingham, K E;
Fegan, C D;
Milligan, D W

Publication type:

Article

Multicentre European study comparing selection techniques for the isolation of CD34+ cells.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1191, doi. 10.1038/sj.bmt.1701789

By:

de Wynter, E A;
Ryder, D;
Lanza, F;
Nadali, G;
Johnsen, H;
Denning-Kendall, P;
Thing-Mortensen, B;
Silvestri, F;
Testa, N G

Publication type:

Article

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1131, doi. 10.1038/sj.bmt.1701790

By:

Reece, D E;
Nevill, T J;
Sayegh, A;
Spinelli, J J;
Brockington, D A;
Barnett, M J;
Klingemann, H-G;
Connors, J M;
Nantel, S H;
Shepherd, J D;
Sutherland, H J;
Voss, N J S;
Fairey, R N;
O’Reilly, S E;
Phillips, G L

Publication type:

Article

Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 11, p. 1205

By:

Müller, B U;
Tichelli, A;
Passweg, J R;
Nissen, C;
Wodnar-Filipowicz, A;
Gratwohl, A

Publication type:

Article

Works matching IS 02683369 AND DT 1999 AND VI 23 AND IP 11

Using at least 5×10<sup>6</sup>/kg CD34<sup>+</sup> cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.

Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.

Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host–donor combination.

Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.

Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD).

Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).

Culturing human umbilical cord blood: a comparison of mononuclear vs CD34<sup>+</sup> selected cells.

A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model.

Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation.

High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths.

Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.

Opportunistic CNS infection after bone marrow transplantation.

Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.

Case Report: Plasmodium vivax causing pancytopenia after allogeneic blood stem cell transplantation in CML.

Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.

Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy.

Multicentre European study comparing selection techniques for the isolation of CD34<sup>+</sup> cells.

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease.

Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation.